Jeremy C. Miller

Van Andel Institute

Papers

1

Total Citations

384

H-Index

1

About

Jeremy C. Miller is a pioneer in the application of antibody microarray technology for serum protein profiling and biomarker discovery. His seminal 2003 work, cited over 380 times, introduced a practical and scalable strategy for simultaneously screening hundreds of proteins from small serum volumes. By comparing protein abundance patterns across 33 prostate cancer patients and 20 healthy controls, Miller demonstrated the power of this high-throughput approach to identify potential diagnostic biomarkers for prostate cancer. This foundational study not only advanced the field of proteomics but also established a methodological framework that has been widely adopted for cancer biomarker discovery. Miller's contributions are particularly notable for bridging the gap between antibody-based array technology and clinical proteomics, enabling researchers to move beyond single-protein analyses toward comprehensive, multiplexed profiling of disease states. His work remains a key reference for scientists developing non-invasive diagnostic tools and continues to influence the design of serum-based cancer detection studies.

Research Focus

Key Achievements

1
H-Index
1
Papers
384
Total Citations
384
Avg Citations/Paper
🏆 Most Cited Paper
Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers
384 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Van Andel Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago